IP Library Granted Patent US 7,011,761
Granted Patent B2
US 7,011,761 · App. 10/280,109 · Granted Mar 14, 2006

Red blood cell processing systems and methods which control red blood cell hematocrit

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,011,761
App. No.
10/280,109
Granted
Mar 14, 2006
Kind
B2
Abstract

Processing systems and methods comprise a separation device that, in use, performs a separation process including separation of red blood cells from blood or a suspension containing red blood cells. The systems and methods include an outlet line coupled to the separation device to remove red blood cells from the separation device, at least in part, while the separation process occurs. A sensor associated with the outlet line senses hematocrit of red blood cells removed from the separation device and generates a sensed hematocrit output. A controller is coupled to the separation device to control removal of red blood cells from the separation device based, at least in part, upon the sensed hematocrit output.

Claims (19)

1. A processing method comprising the steps of

performing a separation process with a separation device including separation of red blood cells and plasma from blood or a suspension containing red blood cells and plasma,

conveying blood or the suspension into the separation device at a controlled blood flow rate Qb, at least in part, while the separation process occurs,

conveying plasma from the separation device at a controlled plasma flow rate Qp, at least in part, while the separation process occurs,

removing red blood cells from the separation device at a red blood cell flow rate Qrbc, at least in part, while the separation process occurs, whereby Qrbc=Qb−Qp,

sensing hematocrit of red blood cells removed from the separation device to generate a sensed hematocrit output, and

controlling a ratio between Qb and Qp based, at least in part, upon the sensed hematocrit output.

2. A method according to claim 1

wherein the separation process generates a centrifugal separation field.

3. A method according to claim 1

wherein the controlling step includes setting Qb at a selected magnitude and varying Qp to control the ratio.

4. A method according to claim 1

wherein the controlling step includes controlling the ratio based, at least in part, upon deviation between the sensed hematocrit output and a predetermined red blood cell hematocrit value.

5. A method according to claim 4

wherein the controlling step includes controlling the ratio based, at least in part, upon magnitude of the deviation.

6. A method according to claim 4

wherein the controlling step includes controlling the ratio based, at least in part, upon change of the deviation over time.

7. A method according to claim 1

wherein the sensing step includes optically sensing the hematocrit of red blood cells removed from the separation device to generate the sensed hematocrit output.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0549 →
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0597 →
SECOND-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 15, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019297/0168 →
FIRST-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019280/0211 →
PATENT ASSIGNMENT Recorded Apr 6, 2007
From: BAXTER INTERNATIONAL INC.
To: FENWAL, INC.
Reel/Frame 019129/0001 →